IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment
Harald Prüß(German Center for Neurodegenerative Diseases), Klaus‐Peter Wandinger(Universität Hamburg), Stephan Köhler(Harvard University), Winfried Stoecker(Universität Hamburg), Josep Dalmau(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Lutz Harms(Universität Hamburg), Jan M. Schwab(The Ohio State University Wexner Medical Center), Ralph Buchert(Universität Hamburg), Dietmar Schmitz(German Center for Neurodegenerative Diseases), Christine Klingbeil(Euroimmun Medizinische Labordiagnostika (Germany)), Nikolaus Maier(Humboldt-Universität zu Berlin), Christian Probst(Mayo Clinic), Ute A. Kopp(Harvard University), Alloysius Gomez(Harvard University), Gudrun Ahnert‐Hilger(Universität Hamburg), Christoph Terborg(University of Göttingen), Markus Höltje(Universität Hamburg)
Cited by 144
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
|The Lancet Neurology|2008|3.5k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
|The Lancet Neurology|2010|2.4k